Skip to main content

Tamoxifen News

Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years

FRIDAY, June 20, 2025 – Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy, according to a study published recently in JNCI:...

Study Supports Tamoxifen for DCIS Early Breast Cancers

MONDAY, Dec. 16, 2024 – The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an early, low-risk form of breast cancer, a new study...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer - Male, Breast Cancer

Tamoxifen patient information at Drugs.com